Cardiovascular Risk Factors and Antiphospholipid Antibodies in Giant Cell Arteritis-Related Thrombosis
Although aPL might be prevalent among GCA, there were minimal associations between aPL isotypes and GCA thrombotic events. Further studies are needed to confirm aPL prevalence in GCA and explore anticoagulation's potential role in patients with visual ischemia and positive aPL. Cite this article as: Hasbani GE, Crowson C, Snyder M, Warrington K, Koster M. Cardiovascular risk factors and antiphospholipid antibodies in giant cell arteritis-related thrombosis. Arch Rheumatol. 2025;40(4):422-426.
Authors
- Matthew J. Koster (ORCID: https://orcid.org/0000-0002-2895-6755)
- Georges El Hasbani (ORCID: https://orcid.org/0000-0003-2571-1450)
- Melissa A. Snyder (ORCID: https://orcid.org/0000-0001-6810-6213)
- Kenneth J. Warrington (ORCID: https://orcid.org/0000-0001-7708-2487)
- Cynthia S. Crowson (ORCID: https://orcid.org/0000-0001-5847-7475)
Institutions
- WinnMed (US)
Publication Details
- Journal
- Archives of Rheumatology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.5152/archrheumatol.2025.11182
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00